The 7-Methylguanosine (m7G) methylation METTL1 acts as a potential biomarker of clear cell renal cell carcinoma progression
Background: Clear cell renal cell carcinoma (ccRCC) is the most common subtype of renal cancer. 7-Methylguanosine (m7G), one of the most prevalent RNA modifications, has been reported to play an important role in ccRCC progression; however, the specific regulators of m7G modification that are involv...
Saved in:
| Main Authors: | Yi Liu, Yanji Zhan, Jiao Liu, Zhengze Shen, Yudong Hu, Ling Zhong, Yuan Yu, Bin Tang, Jing Guo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-01-01
|
| Series: | Translational Oncology |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1936523324003280 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Deciphering the secret codes in N7‐methylguanosine modification: Context‐dependent function of methyltransferase‐like 1 in human diseases
by: Huan Fang, et al.
Published: (2025-02-01) -
Comprehensive analysis of m7G-related genes METTL1 and WDR4 for predicting prognosis and oncogenic functions in prostate cancer
by: Degeng Kong, et al.
Published: (2025-06-01) -
N7-methylguanosine modification in cancers: from mechanisms to therapeutic potential
by: Qihui Wu, et al.
Published: (2025-01-01) -
CAP-m7G: A capsule network-based framework for specific RNA N7-methylguanosine site identification using image encoding and reconstruction layers
by: Peilin Xie, et al.
Published: (2025-01-01) -
Global and single-nucleotide resolution detection of 7-methylguanosine in RNA
by: Silvia D’Ambrosi, et al.
Published: (2024-12-01)